Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Lipocine Inc LPCN

Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for Central Nervous System (CNS) disorders. Its clinical development candidates include: LPCN 1154, oral brexanolone, for treatment of postpartum depression, LPCN 2101 for epilepsy, LPCN 2203 for essential tremor... see more

Recent & Breaking News (NDAQ:LPCN)

Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against Lipocine Inc.

Business Wire July 7, 2016

Lipocine Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors

Business Wire July 7, 2016

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Lipocine Inc. and Certain Officers – LPCN

GlobeNewswire July 6, 2016

Robbins Arroyo LLP: Lipocine, Inc. (LPCN) Misled Shareholders According to a Recently Filed Class Action

Business Wire July 6, 2016

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses to Contact the Firm

Business Wire July 6, 2016

INVESTOR ALERT: Investigation of Lipocine Inc. Announced by Law Offices of Howard G. Smith

Business Wire July 6, 2016

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lipocine Inc. - LPCN

GlobeNewswire July 5, 2016

IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Lipocine Inc. And Reminds Investors With Losses To Contact The Firm

Business Wire July 5, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Lipocine Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 30, 2016 – LPCN

GlobeNewswire July 5, 2016

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Against Lipocine Inc. - LPCN

Business Wire July 1, 2016

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Lipocine, Inc. – LPCN

Business Wire June 30, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Possible Violations of Federal Securities Laws by Certain Officers and Directors of Lipocine, Inc.

Business Wire June 30, 2016

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Investigation Of Lipocine, Inc. And Advises Investors With Losses to Contact the Firm

Business Wire June 29, 2016

Glancy Prongay & Murray Commences Investigation on Behalf of Lipocine Inc. Investors

Business Wire June 29, 2016

Mid-Afternoon Market Update: Dow Jumps Over 250 Points; Diamond Resorts Shares Climb Following Apollo Deal

Benzinga.com  June 29, 2016

7 Biggest Mid-Day Losers For Wednesday

Benzinga.com  June 29, 2016

Mid-Day Market Update: Crude Oil Surges 3%; Galena Biopharma Shares Tumble

Benzinga.com  June 29, 2016

Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Lipocine, Inc. (LPCN)

PR Newswire June 29, 2016

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lipocine, Inc. - LPCN

PR Newswire June 29, 2016

Stocks Hitting 52-Week Lows

Benzinga.com  June 29, 2016